UVE

In the past six months, Universal Insurance Holdings, Inc. reported strong financial results for Q1 and Q2 2026, with adjusted EPS surpassing analyst estimates and Q2 showing a 33.2% annualized adjusted ROE and 4.1% growth in direct premiums written. Its insurance subsidiaries completed their 2026-2027 reinsurance program on May 28, 2026, and a regular cash dividend was declared on July 8, 2026. Analyst ratings varied, with Piper Sandler raising its price target to $45, Weiss Ratings upgrading to 'buy (a-)', and Wall Street Zen upgrading to 'strong-buy', while Zacks Research cut its rating to 'hold'; the consensus target price is around $45.00 with a 'Moderate Buy' rating. UVE shares reached a new 52-week high of $45.34 in October 2026, showing significant gains of 48.3% over the past year and 30.3% year-to-date. Chairman Sean Downes sold 20,000 shares in mid-September 2026, and insider activity over the past 12 months showed $11.0M worth of shares sold with no buying. As of October 8, 2026, the stock was considered 'modestly overvalued' by GuruFocus, with a market price of $46.97 compared to a GF Value™ of $37.97.